Cite
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis.
MLA
Simpson, Eric L., et al. “The Validated Investigator Global Assessment for Atopic Dermatitis (VIGA‐AD™): A Clinical Outcome Measure for the Severity of Atopic Dermatitis.” British Journal of Dermatology, vol. 187, no. 4, Oct. 2022, pp. 531–38. EBSCOhost, https://doi.org/10.1111/bjd.21615.
APA
Simpson, E. L., Bissonnette, R., Paller, A. S., King, B., Silverberg, J. I., Reich, K., Thyssen, J. P., Doll, H., Sun, L., DeLozier, A. M., Nunes, F. P., & Eichenfield, L. F. (2022). The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis. British Journal of Dermatology, 187(4), 531–538. https://doi.org/10.1111/bjd.21615
Chicago
Simpson, Eric L., Robert Bissonnette, Amy S. Paller, Brett King, Jonathan I. Silverberg, Kristian Reich, Jacob P. Thyssen, et al. 2022. “The Validated Investigator Global Assessment for Atopic Dermatitis (VIGA‐AD™): A Clinical Outcome Measure for the Severity of Atopic Dermatitis.” British Journal of Dermatology 187 (4): 531–38. doi:10.1111/bjd.21615.